Efficacies of biological therapies at week 12 in patients with plaque psoriasis in real-world academic clinical practice: a Canadian multicentre retrospective study

Br J Dermatol. 2017 Jul;177(1):297-298. doi: 10.1111/bjd.15069. Epub 2017 Jun 11.

Authors

A Shahbaz¹, J Qiang¹, J E C Marinas², W B Kim², S Greaves³, J Yeung^{4

5

6}

Affiliations

¹ School of Medicine, University of Ottawa, Ottawa, ON, Canada.
² Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
³ Department of Statistical Sciences, University of Toronto, Toronto, ON, Canada.
⁴ Division of Dermatology, Department of Medicine, University of Toronto, Toronto, ON, Canada.
⁵ Sunnybrook Health Sciences Centre, Toronto, ON, Canada.
⁶ Women's College Hospital, Toronto, ON, Canada.

PMID: 27639251
DOI: 10.1111/bjd.15069

No abstract available

Publication types

Letter
Multicenter Study

MeSH terms

Adalimumab / therapeutic use
Adult
Biological Products / therapeutic use*
Biological Therapy / methods*
Canada
Dermatologic Agents / therapeutic use*
Etanercept / therapeutic use
Female
Humans
Infliximab / therapeutic use
Male
Middle Aged
Psoriasis / drug therapy*
Retrospective Studies
Treatment Outcome
Ustekinumab / therapeutic use

Substances

Biological Products
Dermatologic Agents
Infliximab
Ustekinumab
Adalimumab
Etanercept